Multiple synergizing factors contribute to the strength of the CD8+ T cell response against listeriolysin O
D Bruder, AK Nussbaum, DM Gakamsky… - International …, 2006 - academic.oup.com
Immunodominance in CD8+ T cell responses against Listeria monocytogenes is a well-
recognized but still not fully understood phenomenon. From listeriolysin, the major virulence …
recognized but still not fully understood phenomenon. From listeriolysin, the major virulence …
Vaccines for colon cancer
HL Kaufman, J Schlom - … . Eds. Stern PL, Beverely PCL, Carroll …, 2000 - books.google.com
The realistic prospect of developing a vaccine for the treatment or prevention of colon cancer
derives from recent advances in molecular biology and a better understanding of the host …
derives from recent advances in molecular biology and a better understanding of the host …
Patterns of CD8 T cell clonal dominance in response to change in antiretroviral therapy in HIV-infected children
M Kharbanda, S Than, V Chitnis, M Sun, S Chavan… - AIDS, 2000 - journals.lww.com
Objective To examine the influence of change in antiretroviral therapy (ART) on patterns of
CD8 T cell clonal dominance in HIV-infected children. Design Seventeen HIV-infected …
CD8 T cell clonal dominance in HIV-infected children. Design Seventeen HIV-infected …
Suboptimal stimulation by weak agonist epitope variants does not drive dysfunction of HIV-1-specific cytotoxic T lymphocyte clones
Objective: To assess whether weakly recognized epitope variants induce anergy in HIV-1-
specific CD8+ T lymphocyte (CTL) clones as a mechanism of dysfunction. Design: HIV-1 …
specific CD8+ T lymphocyte (CTL) clones as a mechanism of dysfunction. Design: HIV-1 …
The role of cytotoxic T lymphocytes in the evolution of genetically stable viruses
R Khanna, SR Burrows, JM Burrows - Trends in Microbiology, 1997 - cell.com
Although it is a sound conceptual rationale that immune pressure exerted by cytotoxic T
lymphocytes contributes towards the long-term evolution of genetically stable viruses, a …
lymphocytes contributes towards the long-term evolution of genetically stable viruses, a …
Molecular and Functional Dissection of the H-2Db-Restricted Subdominant Cytotoxic T-Cell Response to Lymphocytic Choriomeningitis Virus
D Hudrisier, J Riond, JE Gairin - Journal of Virology, 2001 - Am Soc Microbiol
Infection of H-2 b mice with lymphocytic choriomeningitis virus (LCMV) generates an H-2Db-
restricted cytotoxic T-lymphocyte (CTL) response whose subdominant component is directed …
restricted cytotoxic T-lymphocyte (CTL) response whose subdominant component is directed …
Cancer vaccine development
J Schlom, KY Tsang, JA Kantor, SI Abrams… - Expert Opinion on …, 1998 - Taylor & Francis
Cancer vaccine development Page 1 Schlom, Tsang, Kantor, Abrams, Zaremba, Greiner &
Hodge Cancer vaccine development Monthly Focus: Biologicals & Immunologicals Cancer …
Hodge Cancer vaccine development Monthly Focus: Biologicals & Immunologicals Cancer …
Genetic diversity of the S10 RNA segment of field and vaccine strains of bluetongue virus from the PR China
Y Zhang, X Du, W Li, J Li, J Liu, J Zhu, N Zhang - Archives of virology, 2010 - Springer
Bluetongue virus (BTV) infection of ruminants is endemic throughout tropical and subtropical
regions of the world. However, the molecular epidemiology of BTV infection in China has not …
regions of the world. However, the molecular epidemiology of BTV infection in China has not …
Antigenic variation in microbial evasion of immune responses
GJ Kotwal - e LS, 2001 - Wiley Online Library
Antigenic variation is the means by which certain pathogenic microorganisms evade
immune surveillance. Through a variety of mechanisms, the antigenicity of their surface …
immune surveillance. Through a variety of mechanisms, the antigenicity of their surface …
Peptide-based cancer vaccines
WM Kast - 2000 - taylorfrancis.com
The field of peptide based cancer vaccines has evolved tremendously in the last decade of
this century. The exploration on how to apply the peptide knowledge for vaccination …
this century. The exploration on how to apply the peptide knowledge for vaccination …